Published in Mol Immunol on June 01, 1979
Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci U S A (1983) 2.09
Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody. J Clin Invest (1980) 1.95
Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). EMBO J (1984) 1.82
Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias. J Clin Invest (1984) 1.17
Synthesis by cultured human umbilical vein endothelial cells of two proteins structurally and immunologically related to platelet membrane glycoproteins IIb and IIIa. J Cell Biol (1986) 1.10
On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest (1987) 1.02
Reconstruction of platelet proteins into phospholipid vesicles. Functional proteoliposomes. J Clin Invest (1985) 0.91
Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa. J Clin Invest (1991) 0.87
Surface modifications in the platelets of a patient with alpha-N-acetyl-D-galactosamine residues, the Tn-syndrome. J Clin Invest (1982) 0.86
Inheritance of the human platelet alloantigen, PlA1, in type I Glanzmann's thrombasthenia. J Clin Invest (1981) 0.86
A vitronectin-receptor-related molecule in human placental brush border membranes. Biochem J (1991) 0.81
Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest (1966) 2.43
IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY". J Clin Invest (1961) 2.28
Analysis of platelet membrane glycoprotein polymorphisms in Glanzmann thrombasthenia showed the French gypsy mutation in the alphaIIb gene to be strongly linked to the HPA-1b polymorphism in beta3. J Thromb Haemost (2003) 2.20
Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature (1969) 2.16
Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem (1983) 2.09
The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest (1989) 1.94
T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med (1983) 1.91
A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies. J Clin Invest (1969) 1.91
The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis. Blood (1981) 1.86
Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost (2005) 1.83
On the association of glycoprotein Ib and actin-binding protein in human platelets. J Cell Biol (1985) 1.80
Use of "compatible" platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura. N Engl J Med (1969) 1.71
Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest (1986) 1.71
Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit. J Biol Chem (1995) 1.70
Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest (1988) 1.63
Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest (1981) 1.62
Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes. J Lab Clin Med (1996) 1.58
Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood (1985) 1.54
A study of variables affecting the quality of platelets stored at "room temperature". Transfusion (1976) 1.52
Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood (1998) 1.51
TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion (2003) 1.50
Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood (1994) 1.40
Diagnosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood. J Clin Invest (1983) 1.40
Heparin-induced thrombocytopenia: understanding improves but questions remain. J Lab Clin Med (1996) 1.39
A study of criteria for blood donor deferral. Transfusion (1980) 1.39
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest (1994) 1.38
Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. J Clin Invest (1986) 1.35
Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion (1994) 1.33
Effect of calcium on the stability of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem (1985) 1.31
Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood (1965) 1.28
Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII). N Engl J Med (1983) 1.27
Sites of platelet destruction in idiopathic thrombocytopenic purpura. Br J Haematol (1969) 1.24
Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody. J Clin Invest (1985) 1.23
Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites. J Biol Chem (1990) 1.21
Heparin-induced thrombocytopenia and thrombosis. Am J Hematol (2006) 1.20
Post-transfusion purpura: successful treatment by exchange transfusion. N Engl J Med (1972) 1.18
Increased splenic pooling and the pathogenesis of hypersplenism. Am J Med Sci (1967) 1.18
Blood group A and B antigens are strongly expressed on platelets of some individuals. Blood (2000) 1.17
Detection of drug-dependent antibodies by the 51Cr platelet lysis test: documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazole. Am J Hematol (1977) 1.16
Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion (1990) 1.14
Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest (1978) 1.14
Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets. J Cell Biol (1988) 1.13
A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3. J Biol Chem (1992) 1.11
Expression of HLA-B12, HLA-B8, w4, and w5 on platetelets. Transplant Proc (1977) 1.10
Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome. Blood (1982) 1.10
Synthesis by cultured human umbilical vein endothelial cells of two proteins structurally and immunologically related to platelet membrane glycoproteins IIb and IIIa. J Cell Biol (1986) 1.10
Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis. J Lab Clin Med (2001) 1.10
Cleavage of human von Willebrand factor by platelet calcium-activated protease. Blood (1985) 1.09
Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses. Am J Pathol (1986) 1.09
Febrile transfusion reaction: what blood component should be given next? Vox Sang (1982) 1.08
Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion (1996) 1.07
Development of an automated blood inventory and information system for a regional transfusion service. Transfusion (1970) 1.07
Studies of platelet concentrates stored at 22 C nad 4 C. Transfusion (1973) 1.07
Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest (1985) 1.06
Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia. J Clin Invest (1982) 1.05
Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann's thrombasthenia. J Clin Invest (1978) 1.05
Human platelet fibrinogen: purification and hemostatic properties. Blood (1985) 1.05
Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system. Blood (1990) 1.05
Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed-immunoelectrophoresis. Blood (1981) 1.05
Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. J Clin Invest (1988) 1.03
On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest (1987) 1.02
Synergistic action of two murine monoclonal antibodies that inhibit ADP-induced platelet aggregation without blocking fibrinogen binding. Blood (1987) 1.01
Platelet migration inhibition: a new method for detection of platelet antibodies. Blood (1975) 1.01
Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood (1991) 1.00
Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies. J Immunol (1981) 1.00
Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity. Blood (1991) 1.00
Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis. Blood (1999) 0.99
Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood (1999) 0.98
Clinical significance of platelet-specific antigens and antibodies. Prog Clin Biol Res (1984) 0.98
Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. Blood (1992) 0.98
Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a "new" maternal antiplatelet antibody. Blood (1985) 0.97
Lateral diffusion of lipid probes in the surface membrane of human platelets. An electron-electron double resonance (ELDOR) study. Biophys J (1986) 0.97
Synthesis of analogs of human platelet membrane glycoprotein IIb-IIIa complex by chicken peripheral blood thrombocytes. Proc Natl Acad Sci U S A (1985) 0.96
Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. J Thromb Haemost (2004) 0.95
Cleavage of fibrinogen by human platelet calcium-activated protease. Thromb Res (1984) 0.95
Characterization of the humoral immune response in heparin-induced thrombocytopenia. Am J Hematol (1997) 0.95
Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost (2011) 0.94
Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol (1994) 0.94
Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br J Haematol (1996) 0.94
The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Blood (1992) 0.94
The biochemistry of platelet-specific alloantigens. Curr Stud Hematol Blood Transfus (1986) 0.93
Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays. Transfusion (2003) 0.93
Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood (1999) 0.92
Changes associated with platelet aging. Thromb Diath Haemorrh (1972) 0.92
Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers. Transfusion (1996) 0.92
Treatment of thrombotic thrombocytopenic purpura by exchange transfusion. Am J Hematol (1977) 0.92
Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. Biochem J (1996) 0.92
Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. J Lab Clin Med (1978) 0.92
Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol (1977) 0.92
Heparin-induced thrombocytopenia and thrombosis. N Engl J Med (1995) 0.92